Spatial atrophy subtypes are associated with specific sociodemographic, comorbidity, pathologic, and cognitive factors in a representative community‐based cohort: a HABS‐HD study

Abstract

Background: Biological heterogeneity is associated with heterogeneity in clinical outcomes and response to treatment in Alzheimer's disease (AD). Spatial atrophy subtypes are consistently observed across studies, although the generalizability of prior work is unknown due to limited variability within clinic‐based cohorts.

The paper